PROEHL GERALD T 13D/13G Filings for Dermata Therapeutics, Inc. (DRMA)

PROEHL GERALD T 13D and 13G filings for Dermata Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-04-03
6:00 pm
Purchase
2025-03-2713DDERMATA THERAPEUTICS INC
DRMA
PROEHL GERALD T80,410
7.800%
35increase
(+0.04%)
Filing
2025-02-13
6:00 pm
Unchanged
2025-01-2413DDERMATA THERAPEUTICS INC
DRMA
PROEHL GERALD T80,375
15.000%
0
(Unchanged)
Filing
2025-01-23
9:54 pm
Purchase
2025-01-2113DDERMATA THERAPEUTICS INC
DRMA
PROEHL GERALD T80,375
16.000%
78,821increase
(+5072.14%)
Filing
2023-01-18
5:01 pm
Purchase
2022-08-1213DDERMATA THERAPEUTICS INC
DRMA
PROEHL GERALD T1,550
28.900%
26increase
(+1.71%)
Filing
2022-05-05
5:00 pm
Purchase
2022-04-2513DDERMATA THERAPEUTICS INC
DRMA
PROEHL GERALD T1,524
37.700%
136increase
(+9.80%)
Filing
2021-08-27
5:00 pm
Purchase
2021-08-1713DDERMATA THERAPEUTICS INC
DRMA
PROEHL GERALD T1,388
39.200%
1,388increase
(New Position)
Filing